Related Experiment Videos

Comparison of percutaneous endopyelotomy with open pyeloplasty for pediatric ureteropelvic junction obstruction

E M Schenkman1, W F Tarry

  • 1Department of Urology, West Virginia University, Morgantown, USA.

The Journal of Urology
|February 25, 1998
PubMed

Insights

Percutaneous endopyelotomy is effective for primary ureteropelvic junction obstruction in children, similar to open pyeloplasty. However, this minimally invasive approach incurs higher costs and operative times.

Area of Science:

  • Pediatric Urology
  • Minimally Invasive Surgery
  • Urologic Oncology

Background:

  • Ureteropelvic junction obstruction (UPJO) is a common cause of hydronephrosis in children.
  • Percutaneous endopyelotomy (EP) is established for adult UPJO and secondary pediatric UPJO.
  • Limited data exists on EP as a primary treatment for pediatric UPJO.

Purpose of the Study:

  • To evaluate the efficacy of percutaneous endopyelotomy (EP) as a primary treatment for ureteropelvic junction obstruction (UPJO) in children.
  • To compare EP outcomes with traditional open pyeloplasty in pediatric patients.

Main Methods:

  • A comparative study of 8 pediatric patients undergoing primary EP versus 20 undergoing open pyeloplasty for UPJO.
  • Preoperative diagnosis confirmed via ultrasound, IVP, or renal scan.
  • Postoperative follow-up of 1.5 to 3 years, assessing success through imaging and clinical findings.

Main Results:

  • Overall success rates were comparable: 88% for EP and 93% for open pyeloplasty.
  • One failure occurred in each treatment group.
  • Hospital stays were similar, but EP involved longer operative times and higher hospital costs.

Conclusions:

  • Percutaneous endopyelotomy (EP) is an effective option for primary ureteropelvic junction obstruction (UPJO) in pediatric patients.
  • While successful, EP is associated with increased costs compared to open pyeloplasty.
Abstract

Related Concept Videos